About
SARAH DiSALVATORE, MPH
I am a Clinical Operations Professional with 30 years of experience leading global clinical development across biotech and pharma. I provide strategic guidance on trial planning, oversight, vendor management, and quality systems to ensure studies run efficiently, remain compliant, and generate high-quality data.
I’ve held leadership roles at Ascidian Therapeutics, AGTC, Rocket Pharma, Stemline Therapeutics, Helsinn, Roche, and ImClone Systems. My work spans rare disease, ophthalmology, oncology, neurology, and infectious disease. I’ve worked on gene therapies, biologics, monoclonal antibodies, and small molecules for adult and pediatric populations worldwide.
As a Rare Parent and Board Member of the DDX3X Foundation www.ddx3x.com. I am personally committed to advancing rare disease research. I hold an MPH in Epidemiology from New York Medical College and a B.A. in Biology from Salisbury University.